- Home
- LGTY vs IMTX Comparison
LGTY vs IMTX Comparison
Compare LGTY & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGTY
- IMTX
- Stock Information
- Founded
- LGTY 1970
- IMTX N/A
- Country
- LGTY United States
- IMTX Germany
- Employees
- LGTY N/A
- IMTX 343
- Industry
- LGTY
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LGTY
- IMTX Health Care
- Exchange
- LGTY NYSE
- IMTX Nasdaq
- Market Cap
- LGTY 501.6M
- IMTX 559.1M
- IPO Year
- LGTY N/A
- IMTX N/A
- Fundamental
- Price
- LGTY $14.08
- IMTX $4.60
- Analyst Decision
- LGTY Hold
- IMTX Strong Buy
- Analyst Count
- LGTY 1
- IMTX 4
- Target Price
- LGTY N/A
- IMTX $16.67
- AVG Volume (30 Days)
- LGTY 727.6K
- IMTX 1.1M
- Earning Date
- LGTY 02-20-2025
- IMTX 03-20-2025
- Dividend Yield
- LGTY 3.13%
- IMTX N/A
- EPS Growth
- LGTY N/A
- IMTX N/A
- EPS
- LGTY 0.10
- IMTX N/A
- Revenue
- LGTY $101,873,000.00
- IMTX $128,824,447.00
- Revenue This Year
- LGTY $1.99
- IMTX $116.22
- Revenue Next Year
- LGTY $3.46
- IMTX N/A
- P/E Ratio
- LGTY $147.14
- IMTX N/A
- Revenue Growth
- LGTY N/A
- IMTX 52.53
- 52 Week Low
- LGTY $8.41
- IMTX $4.48
- 52 Week High
- LGTY $14.20
- IMTX $13.77
- Technical
- Relative Strength Index (RSI)
- LGTY N/A
- IMTX 27.20
- Support Level
- LGTY N/A
- IMTX $4.85
- Resistance Level
- LGTY N/A
- IMTX $5.25
- Average True Range (ATR)
- LGTY 0.00
- IMTX 0.28
- MACD
- LGTY 0.00
- IMTX -0.01
- Stochastic Oscillator
- LGTY 0.00
- IMTX 8.96
About LGTY LOGILITY SUPPLY CHAIN SOLUTIONS INC
Logility Supply Chain Solutions Inc develops enterprise management and supply chain-related software and services. Its Services include Scenario Planning Products, Demand Planning InventoryAI+, Supply, Deployment, Supply Chain Data Management, and Supply Chain Design. The group provides services to various industries such as Food and Beverage Consumer Packaged Goods, Process Manufacturing, Industrial Manufacturing, Chemicals, and others.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.